Company

Thermo Fisher Scientific Inc TMO

Tracked across 13 disclosed holders on Protégé.

10 tracked investors, latest 13F quarter ending 30 Sep 2026 · 2 members of Congress · 1 executive · latest filing 20 Oct 2026

Held by these investors

All of 10 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Veritas Asset Management8.0%$442.6M2026-06-302026-08-04
Farallon Capital Management3.1%$526.0M2026-06-302026-08-14
Andreas Halvorsen2.8%$971.3M2026-06-302026-08-14
Egerton Capital1.4%$133.8M2026-09-302026-10-20
Woodline Partners0.5%$158.6M2026-06-302026-08-14
Alyeska Investment Group0.5%$188.5M2026-06-302026-08-14
Winton Capital Management0.5%$14.2M2026-06-302026-08-07
Balyasny Asset Management0.4%$225.4M2026-06-302026-08-14
Sculptor Capital Management0.3%$20.6M2026-06-302026-08-14
Element Capital Management0.1%$2.0M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Michael Rulli0 buys / 1 sell-$8K2024-12-12
Dwight Evans0 buys / 1 sell-$8K2026-05-07

Company executives who disclosed trades

Executives' own trades in this company's stock. Source: SEC Form 4; latest trade date per row.
ExecutiveDisclosed activityNetLatest trade
Marc Casper0 buys / 32 sells-$128.9M2026-08-24

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for TMO